Suppr超能文献

EAU 指南:阴茎癌 2014 年更新版

EAU guidelines on penile cancer: 2014 update.

机构信息

Department of Urology, University Hospital Rostock, Rostock, Germany.

Department of Pathology, Hôpital La Pitié-Salpétrière, Université Pierre et Marie Curie University Paris VI, Paris, France.

出版信息

Eur Urol. 2015 Jan;67(1):142-150. doi: 10.1016/j.eururo.2014.10.017. Epub 2014 Nov 1.

Abstract

CONTEXT

Penile cancer has high mortality once metastatic spread has occurred. Local treatment can be mutilating and devastating for the patient. Progress has been made in organ-preserving local treatment, lymph node management, and multimodal treatment of lymphatic metastases, requiring an update of the European Association of Urology guidelines.

OBJECTIVE

To provide an evidence-based update of treatment recommendations based on the literature published since 2008.

EVIDENCE ACQUISITION

A PubMed search covering the period from August 2008 to November 2013 was performed, and 352 full-text papers were reviewed. Levels of evidence were assessed and recommendations graded. Because there is a lack of controlled trials or large series, the levels of evidence and grades of recommendation are low compared with those for more common diseases.

EVIDENCE SYNTHESIS

Penile squamous cell carcinoma occurs in distinct histologic variants, some of which are related to human papilloma virus infection; others are not. Primary local treatment should be organ preserving, if possible. There are no outcome differences between local treatment modes in superficial and T1 disease. Management of inguinal lymph nodes is crucial for prognosis. In impalpable nodes, invasive staging should be done depending on the risk factors of the primary tumour. Lymph node metastases should be treated by surgery and adjuvant chemotherapy in N2/N3 disease.

CONCLUSIONS

Organ preservation has become the standard approach to low-stage penile cancer, whereas in lymphatic disease, it is recognised that multimodal treatment with radical inguinal node surgery and adjuvant chemotherapy improves outcome.

PATIENT SUMMARY

Approximately 80% of penile cancer patients of all stages can be cured. With increasing experience in the management of penile cancer, it is recognized that organ-preserving treatment allows for better quality of life and sexual function and should be offered to all patients whenever feasible. Referral to centres with experience is recommended.

摘要

背景

一旦发生转移性扩散,阴茎癌的死亡率很高。局部治疗可能会对患者造成严重的伤害和破坏。在保留器官的局部治疗、淋巴结管理以及淋巴转移的多模式治疗方面已经取得了进展,这需要更新欧洲泌尿外科学会的指南。

目的

根据 2008 年以来发表的文献,提供基于循证医学的治疗建议更新。

证据获取

进行了一项从 2008 年 8 月至 2013 年 11 月的 PubMed 搜索,共查阅了 352 篇全文文章。评估了证据水平并对建议进行了分级。由于缺乏对照试验或大型系列研究,与更常见疾病相比,证据水平和推荐等级都较低。

证据综合

阴茎鳞状细胞癌有不同的组织学变异,其中一些与人类乳头瘤病毒感染有关,另一些则无关。如果可能的话,原发部位的局部治疗应保留器官。在表浅和 T1 疾病中,局部治疗方式的结果没有差异。腹股沟淋巴结的管理对预后至关重要。对于不可触及的淋巴结,应根据原发肿瘤的危险因素进行侵袭性分期。对于 N2/N3 疾病,淋巴结转移应通过手术和辅助化疗进行治疗。

结论

对于低分期的阴茎癌,保留器官已成为标准治疗方法,而在淋巴疾病中,多模式治疗包括根治性腹股沟淋巴结手术和辅助化疗,可改善预后。

患者总结

大约 80%的各期阴茎癌患者可以治愈。随着对阴茎癌管理经验的增加,人们认识到保留器官的治疗方法可以提高生活质量和性功能,并且只要可行,应向所有患者提供。建议向有经验的中心转诊。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验